Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT06142487 Not yet recruiting - Acne Vulgaris Clinical Trials

Assessment of the Effects of Silk Pillowcases on Acne Prone Skin

Start date: November 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of using silk pillowcases in mild to moderate non-cystic acne prone skin in comparison to cotton pillowcases.

NCT ID: NCT06141330 Not yet recruiting - Acne Vulgaris Clinical Trials

Vitamin D Supplementation in Acne

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is: • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone. Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid. Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.

NCT ID: NCT05899699 Not yet recruiting - Acne Vulgaris Clinical Trials

Effect of New Topical Preparation for Treatment of Acne Vulgaris

Start date: June 5, 2023
Phase: Phase 2
Study type: Interventional

The investigators propose a randomized, double-blind control trial study to evaluate the efficacy and safety of the optimized topical combination ME of the investigated drugs in the treatment of acne vulgaris containing DAP-FLU in comparison with standard therapy of Adapalene at Mansoura University Dermatology and Andrology Outpatient Clinic.

NCT ID: NCT05885217 Not yet recruiting - Acne Vulgaris Clinical Trials

Measurement of Serum microRNA in Acne Vulgaris Patient

Start date: August 2023
Phase:
Study type: Observational

The aim of the study is to: 1. Evaluation of serum microRNA in acne vulgaris and compare to control group 2. Evaluate correlation with acne vulgaris severity

NCT ID: NCT05869188 Not yet recruiting - Acne Vulgaris Clinical Trials

Effect of Systemic Isotretinoin on Serum Irisin Level in Acne Vulgaris Patients

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Acne vulgaris is a chronic inflammatory skin disease affecting the pilosebaceous unit. It is clinically characterized by comedones, papules, pustules, nodules, cysts and scarring on the face and trunk. The severity of the disease ranges from mild comedonal acne to severe nodulocystic acne which can be permanently disfiguring.In addition to the physical lesions, the disease can have a profound psychologic impact, contributing to low self-esteem, depression and anxiety.In addition to the physical lesions, the disease can have a profound psychologic impact, contributing to low self-esteem, depression and anxiety.

NCT ID: NCT05783778 Not yet recruiting - Acne Vulgaris Clinical Trials

Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Acne vulgaris is one if the most common chronic inflammatory skin disorders.Acne is characterized by forming of inflammatory and non inflammatory lesions mainly on the Face,neck,arms, upper trunk and back

NCT ID: NCT05737758 Not yet recruiting - Acne Clinical Trials

Investigating Clinical Trial Participation for Acne Patients

Start date: March 2024
Phase:
Study type: Observational

Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will scrutinize the experiences of patients diagnosed with acne as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future acne patients.

NCT ID: NCT05666765 Not yet recruiting - Acne Vulgaris Clinical Trials

Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris

Start date: January 1, 2023
Phase: Phase 4
Study type: Interventional

This study aims to compare the effects of isotretinoin and silymarin or both in treatment of acne and their effects on the level of IGF-1, SAA1 and malondialdehyde (MDA) in acne patients.

NCT ID: NCT05582434 Not yet recruiting - Acne Clinical Trials

Experience With Topical Acne Treatment

Start date: July 2024
Phase: Early Phase 1
Study type: Interventional

Acne is a chronic condition that typically requires the use of multiple medications.1 Medication adherence is especially challenging for patients with chronic diseases and often decreases over time, especially for those using topical medications.1 Nonadherence can result in multiple negative effects including treatment failure, increased healthcare costs, and decreased quality of life. Primary nonadherence refers to problems acquiring and starting treatment. Challenges to this form of nonadherence include a lack of knowledge, misunderstanding of usage, poor communication with provider, increased cost, and fear of side effects.2 Secondary nonadherence refers to when the patient does not use the medication as prescribed. Hurdles to secondary nonadherence include delayed results, increased complexity of treatment plan, adverse effects, busy lifestyle, and inconvenience.2

NCT ID: NCT05579171 Not yet recruiting - Acne Scars Clinical Trials

Lasers to Aid in Treatment of Acne Scars

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

To assess efficacy and safety of paired picosecond 755nm Alexandrite laser with focused lens array (PSAL; Picosure®, Cynosure, Westford, MA) and radiofrequency microneedling (RFM; Potenza™, Cynosure, Westford, MA) for treatment of facial, atrophic acne scars.